CS
RXDX
Candriam SCA’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-90,000
| Closed | -$8.89M | – | 897 |
|
|
2023
Q1 | $8.89M | Buy |
90,000
+15,000
| +20% | +$1.48M | 0.06% | 271 |
|
|
2022
Q4 | $8.25M | Sell |
75,000
-15,000
| -17% | -$1.65M | 0.06% | 309 |
|
|
2022
Q3 | $5.31M | Buy |
+90,000
| New | +$5.31M | 0.04% | 365 |
|